Sort   by:  
 Page size 
TranscriptomicsGenome-wide SNP array data from Human Variation Panel by Illumina 650K
Radiation therapy is used to treat half of all cancer patients. Response to radiation therapy varies widely among patients. Therefore, we performed a genome-wide association study (GWAS) to identify biomarkers to help predict radiation response using 277 ethnically defined human lymphoblastoid cell ...
ORGANISM(S): Homo sapiens 
2010-09-25 | E-GEOD-24274 | biostudies-arrayexpress
TranscriptomicsGenome-wide SNP array data from Human Variation Panel by Illumina 550K
Radiation therapy is used to treat half of all cancer patients. Response to radiation therapy varies widely among patients. Therefore, we performed a genome-wide association study (GWAS) to identify biomarkers to help predict radiation response using 277 ethnically defined human lymphoblastoid cell ...
ORGANISM(S): Homo sapiens 
2010-09-24 | E-GEOD-24260 | biostudies-arrayexpress
TranscriptomicsGenome-wide SNP array data from Human Variation Panel by Illumina 510S
Radiation therapy is used to treat half of all cancer patients. Response to radiation therapy varies widely among patients. Therefore, we performed a genome-wide association study (GWAS) to identify biomarkers to help predict radiation response using 277 ethnically defined human lymphoblastoid cell ...
ORGANISM(S): Homo sapiens 
2010-09-24 | E-GEOD-24245 | biostudies-arrayexpress
UnknownBRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
Not available
S-EPMC6067803 | biostudies-literature
TranscriptomicsTranscription profiling of 287 lymphoblastoid cell lines
We used microarrays to identify the variation of basal gene expression level among 287 lymphoblastoid cell lines. Radiation therapy is used to treat half of all cancer patients. Response to radiation therapy varies widely among patients. Therefore, we performed a genome-wide association study (GWA...
ORGANISM(S): Homo sapiens 
2010-07-24 | E-GEOD-23120 | biostudies-arrayexpress
UnknownEffect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Not available
S-EPMC7448831 | biostudies-literature
GenomicsA Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on NCIC CTG Trial MA.27 Evaluating Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine.

Source of Patients
The source of the patients for this genome-wide case control study was MA.27, which was conducted as a multi-cooperative group effort under the auspices of the NCI Breast Cancer Intergroup of North America. The NCIC Clinical Trials Group (CTG) serves as the co...

phs000210.v1.p1 | EGA
GenomicPROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)

The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer that may identify an individualized treatment approach for men with the disease.

Understanding the molecular biology behind castration-resistant prosta...

phs001141 | dbGaP
Sort   by:  
 Page size